Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Lau

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 2, 2024
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expressionPhilip Kienzl, Abigail J Deloria, Monika Hunjadi, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
BMJ Open|May 30, 2023
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT studyNoemi Auxiliadora Fuentes Bolanos, Bhavna Padhye, Macabe Daley, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 2, 2024
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expressionPhilip Kienzl, Abigail J Deloria, Monika Hunjadi, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
BMJ Open|May 30, 2023
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT studyNoemi Auxiliadora Fuentes Bolanos, Bhavna Padhye, Macabe Daley, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Pageof 6